The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Inflammatory and Pro-inflammatory cytokines changes
Timeframe: 12 weeks
Change in Ocular Surface Disease Index (OSDI)
Timeframe: 4, 8 , and 12 weeks